This free survey is powered by
  1. Surveys
  2. 2013
  3. June
  4. H
  5. Health Outcomes
0%
Exit Survey
 
 
1. To the best of your knowledge, what was the average incidence of Vitamin K deficiency related complications observed within your patients after initiating Warfarin therapy within the last year.
 
Less than 10
 
11-20 cases
 
21-30 cases
 
31-40 cases
 
41-50 cases
 
More than 50 cases
 
 
 
2. Prior to participating in the nutrition education program, Nourishment on Warfarin, were you comfortable with prescribing Vitamin K to Warfarin patients?
 
Yes
 
No
 
Somewhat
 
 
 
3. Since participating in the program have you changed the level of education provided to your patients?
 
Yes
 
No
 
 
 
4. Since providing additional patient education to include proper ways to consume Vitamin K while on Warfarin, has there been a change in the incidence of deficiency related complications?
 
Yes
 
No
 
Somewhat
 
 
 
5. Please describe the change seen in development of Vitamin K deficiency related complications since quality of Vitamin K and Warfarin patient education was improved
   
 
 
 
6. Have your patients provided feedback or have you observed any change to the quality of life in previous Warfarin patients after providing additional Vitamin K education. Please explain
   
 
 
 
7. Since instructing patients on how to properly consume Vitamin K, how difficult has it been to stabilize INR. If difficulty was NOT observed and you selected VERY EASY or MOST TIMES EASY, please skip questions 8a-8d.
 
 
 
8a. What instructions were provided to the patient(s)
   
8b. Were you aware of the patient's compliance level? If so, how compliant were they? If not, please explain what occurred?
   
8c. How often was INR checked?
   
8d. Do you feel you need additional training? If so, please indicate the specific areas of concern.
   
 
 
 
9a. Do you think drug-nutrition education programs such as Nourishment on Warfarin are beneficial for your practice? Why or why not? How has the additional knowledge assisted you with caring for your patients?
   
9b. Did you observe a reduction in the number of visits to stabilize INR since correcting patient education? If not, what complications did you encounter?
   
 
 
 
10. What additional drug-food-nutrition education programs would you be interested in?